Getting identical performance from lab to commercial scale is tough, but DMC’s platform tech makes it happen with efficient development, scaling, and commercialization of biobased products. DMC’s Matt Lipscomb shared this illuminating slide guide at ABLC in San Francisco recently.

Use your ← → (arrow) keys to browse